Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

106.04
Delayed Data
As of Dec 09
 +3.30 / +3.21%
Today’s Change
89.76
Today|||52-Week Range
177.93
-29.00%
Year-to-Date
No recent news for Intercept Pharmaceuticals Inc.

Today’s Trading

Previous close102.74
Today’s open103.43
Day’s range103.43 - 106.92
Volume441,191
Average volume (3 months)437,649
Market cap$2.6B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+29.86%
Earnings growth (this year)-65.35%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+59.74%
P/E ratioNM
Price/Sales1,272.01
Price/Book4.30

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+0.06+0.10%
PBHPrestige Brands Hold...+0.56+1.20%
MDCOMedicines Co+2.03+6.19%
HZNPHorizon Pharma PLC-0.20-1.33%
Data as of 4:02pm ET, 12/09/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$3.70
Annual revenue (last year)$2.8M
Annual profit (last year)-$226.4M
Net profit margin-8,139.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer
Sandip Kapadia
Corporate headquarters
New York, New York

Forecasts


Search for Jobs